Pharma Nord continues on positive course
The food supplements company presented a significantly improved result for 2012. The CEO believes that pharmaceutical registrations of food supplement ingredients can lead to new possibilities – and a dispute over a private jet has finally been settled.
by Henrik Tüchsen
The major Danish food supplements group, Pharma Nord, is continuing along the positive course with lower costs, no more private jets, fewer interest expenses, far fewer currency risks, and thus a growing turnover for 2012.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
